NewReferencesToProblem: verschil tussen versies

Uit Zorginformatiebouwstenen
Ga naar: navigatie, zoeken
(Uitvoering)
(Realisation)
 
(13 tussenliggende versies door dezelfde gebruiker niet weergegeven)
Regel 3: Regel 3:
 
Upon acceptance of the revision of the HCIM Problem, in release 2024 the HCIM Problem will disappear. This means that HCIMs currently referring to the HCIM Problem will have to be modified.<br> The HCIM Problem represented multiple concepts and these have been modelled in separate HCIMs after the revision of the HCIM Problem.
 
Upon acceptance of the revision of the HCIM Problem, in release 2024 the HCIM Problem will disappear. This means that HCIMs currently referring to the HCIM Problem will have to be modified.<br> The HCIM Problem represented multiple concepts and these have been modelled in separate HCIMs after the revision of the HCIM Problem.
  
===Uitvoering===
+
===Realisation===
 
The following HCIMs are eligable to replace the reference to the HCIM Problem:
 
The following HCIMs are eligable to replace the reference to the HCIM Problem:
 
*[[Condition-v1.0(2024EN) |Condition]]
 
*[[Condition-v1.0(2024EN) |Condition]]
Regel 18: Regel 18:
 
|Current reference
 
|Current reference
 
|Replacement reference(s)
 
|Replacement reference(s)
|Old information model
+
|style="text-align:center;" |Current information model
|New information model
+
|style="text-align:center;" |New information model
 
|-style="vertical-align: top;"
 
|-style="vertical-align: top;"
|width="20%" |[[Alert-v4.2(2024EN)| Alert]]
+
|width="20%" |[[Admission-v2.0(2024EN)| Admission]]
|width="20% |[[Problem-v4.7(2024EN)|Problem]]
+
|width="20%" |[[Problem-v4.7(2024EN)|Problem]]
|width="20%" |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]
+
|width="20%" |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
 +
|style="text-align:center;" |[[Bestand:Admission-v2.0Model(2024EN).png | 150px |link=]]<br>[[Media:Admission-v2.0Model(2024EN).png | full-size]]
 +
|style="text-align:center;" |[[Bestand:Admission-v2.0Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:Admission-v2.0Model(2024EN)_Nieuw.png | full-size]]
 +
 
 +
|-style="vertical-align: top;"
 +
|[[AdvanceDirective-v4.3(2024EN)| AdvanceDirective]]
 +
|[[Problem-v4.7(2024EN)|Problem]]
 +
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]
 +
|style="text-align:center;" |[[Bestand:AdvanceDirective-v4.3Model(2024EN).png | 150px |link=]]<br>[[Media:AdvanceDirective-v4.3Model(2024EN).png | full-size]]
 +
|style="text-align:center;" |[[Bestand:AdvanceDirective-v4.3Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:AdvanceDirective-v4.3Model(2024EN)_Nieuw.png | full-size]]
 +
|-style="vertical-align: top;"
 +
|[[Alert-v4.2(2024EN)| Alert]]
 +
|[[Problem-v4.7(2024EN)|Problem]]
 +
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]] [[#Notes | <sup>1</sup>]]
 
|style="text-align:center;" | [[Bestand:Alert-v4.2Model(2024EN).png | 150px |link=]]<br>[[Media:Alert-v4.2Model(2024EN).png | full-size]]
 
|style="text-align:center;" | [[Bestand:Alert-v4.2Model(2024EN).png | 150px |link=]]<br>[[Media:Alert-v4.2Model(2024EN).png | full-size]]
|
+
|style="text-align:center;" | [[Bestand:Alert-v4.2Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:Alert-v4.2Model(2024EN)_Nieuw.png | full-size]]
 +
|-style="vertical-align: top;"
 +
|[[CareAgreement-v1.1(2024EN)| CareAgreement]]
 +
|[[Problem-v4.7(2024EN)|Problem]]
 +
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]
 +
|style="text-align:center;" |[[Bestand:CareAgreement-v1.1Model(2024EN).png | 150px |link=]]<br>[[Media:CareAgreement-v1.1Model(2024EN).png | full-size]]
 +
|style="text-align:center;" |[[Bestand:CareAgreement-v1.1Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:CareAgreement-v1.1Model(2024EN)_Nieuw.png | full-size]]
 
|-style="vertical-align: top;"
 
|-style="vertical-align: top;"
|[[TreatmentObjective-v3.2.1(2024EN)| TreatmentObjective]]
+
|[[CareTeam-v1.0.1(2024EN)| CareTeam]]
 
|[[Problem-v4.7(2024EN)|Problem]]
 
|[[Problem-v4.7(2024EN)|Problem]]
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
+
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
|style="text-align:center;" | [[Bestand:TreatmentObjective-v3.2.1Model(2024EN).png | 150px |link=]]<br>[[Media:TreatmentObjective-v3.2.1Model(2024EN).png | full-size]]
+
|style="text-align:center;" |[[Bestand:CareTeam-v1.0.1Model(2024EN).png | 150px |link=]]<br>[[Media:CareTeam-v1.0.1Model(2024EN).png | full-size]]
|style="text-align:center;" | [[Bestand:TreatmentObjective_Nieuw(2024EN).png | 150px |link=]]<br>[[Media:TreatmentObjective_Nieuw(2024EN).png | full-size]]
+
|style="text-align:center;" |[[Bestand:CareTeam-v1.0.1Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:CareTeam-v1.0.1Model(2024EN)_Nieuw.png | full-size]]
 
|-style="vertical-align: top;"
 
|-style="vertical-align: top;"
 
|[[Encounter-v6.0(2024EN)| Encounter]]
 
|[[Encounter-v6.0(2024EN)| Encounter]]
Regel 37: Regel 56:
 
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
 
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
 
|style="text-align:center;" |[[Bestand:Encounter-v6.0Model(2024EN).png | 150px |link=]]<br>[[Media:Encounter-v6.0Model(2024EN).png | full-size]]
 
|style="text-align:center;" |[[Bestand:Encounter-v6.0Model(2024EN).png | 150px |link=]]<br>[[Media:Encounter-v6.0Model(2024EN).png | full-size]]
|
+
|style="text-align:center;" |[[Bestand:Encounter-v6.0Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:Encounter-v6.0Model(2024EN)_Nieuw.png | full-size]]
 +
|-style="vertical-align: top;"
 +
|[[EpisodeOfCare-v1.0(2024EN)| EpisodeOfCare]]
 +
|[[Problem-v4.7(2024EN)|Problem]]
 +
|[[Condition-v1.0(2024EN) | Condition]] [[#Notes | <sup>2</sup>]]
 +
|style="text-align:center;" |[[Bestand:EpisodeOfCare-v1.0Model(2024EN).png | 150px |link=]]<br>[[Media:EpisodeOfCare-v1.0Model(2024EN).png | full-size]]
 +
|style="text-align:center;" |[[Bestand:EpisodeOfCare-v1.0Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:EpisodeOfCare-v1.0Model(2024EN)_Nieuw.png | full-size]]
 
|-style="vertical-align: top;"
 
|-style="vertical-align: top;"
 
|[[FamilyHistory-v4.0(2024EN)| FamilyHistory]]
 
|[[FamilyHistory-v4.0(2024EN)| FamilyHistory]]
Regel 43: Regel 68:
 
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]
 
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]
 
|style="text-align:center;" |[[Bestand:FamilyHistory-v4.0Model(2024EN).png | 150px |link=]]<br>[[Media:FamilyHistory-v4.0Model(2024EN).png | full-size]]
 
|style="text-align:center;" |[[Bestand:FamilyHistory-v4.0Model(2024EN).png | 150px |link=]]<br>[[Media:FamilyHistory-v4.0Model(2024EN).png | full-size]]
|
+
|style="text-align:center;" |[[Bestand:FamilyHistory-v4.0Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:FamilyHistory-v4.0Model(2024EN)_Nieuw.png | full-size]]
 
|-style="vertical-align: top;"
 
|-style="vertical-align: top;"
|[[SkinDisorder-v3.4(2024EN)| SkinDisorder]]
+
|[[MedicalDevice-v4.0(2024EN)| MedicalDevice]]
 
|[[Problem-v4.7(2024EN)|Problem]]
 
|[[Problem-v4.7(2024EN)|Problem]]
 
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]
 
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]
|style="text-align:center;" |[[Bestand:SkinDisorder-v3.4Model(2024EN).png | 150px |link=]]<br>[[Media:SkinDisorder-v3.4Model(2024EN).png | full-size]]
+
|style="text-align:center;" |[[Bestand:MedicalDevice-v4.0Model(2024EN).png | 150px |link=]]<br>[[Media:MedicalDevice-v4.0Model(2024EN).png | full-size]]
|
+
|style="text-align:center;" |[[Bestand:MedicalDevice-v4.0Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:MedicalDevice-v4.0Model(2024EN)_Nieuw.png | full-size]]
 
|-style="vertical-align: top;"
 
|-style="vertical-align: top;"
 
|[[MedicationAgreement-v3.0(2024EN)| MedicationAgreement]]
 
|[[MedicationAgreement-v3.0(2024EN)| MedicationAgreement]]
Regel 55: Regel 80:
 
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
 
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
 
|style="text-align:center;" |[[Bestand:MedicationAgreement-v3.0Model(2024EN).png | 150px |link=]]<br>[[Media:MedicationAgreement-v3.0Model(2024EN).png | full-size]]
 
|style="text-align:center;" |[[Bestand:MedicationAgreement-v3.0Model(2024EN).png | 150px |link=]]<br>[[Media:MedicationAgreement-v3.0Model(2024EN).png | full-size]]
|
+
|style="text-align:center;" |[[Bestand:MedicationAgreement-v3.0Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:MedicationAgreement-v3.0Model(2024EN)_Nieuw.png | full-size]]
|-style="vertical-align: top;"
 
|[[MedicalDevice-v4.0(2024EN)| MedicalDevice]]
 
|[[Problem-v4.7(2024EN)|Problem]]
 
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]
 
|style="text-align:center;" |[[Bestand:MedicalDevice-v4.0Model(2024EN).png | 150px |link=]]<br>[[Media:MedicalDevice-v4.0Model(2024EN).png | full-size]]
 
|
 
|-style="vertical-align: top;"
 
|[[Admission-v2.0(2024EN)| Admission]]
 
|[[Problem-v4.7(2024EN)|Problem]]
 
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
 
|style="text-align:center;" |[[Bestand:Admission-v2.0Model(2024EN).png | 150px |link=]]<br>[[Media:Admission-v2.0Model(2024EN).png | full-size]]
 
|
 
 
|-style="vertical-align: top;"
 
|-style="vertical-align: top;"
 
|[[MultidisciplinaryTeamMeeting-v2.0(2024EN)| MultidisciplinaryTeamMeeting]]
 
|[[MultidisciplinaryTeamMeeting-v2.0(2024EN)| MultidisciplinaryTeamMeeting]]
Regel 73: Regel 86:
 
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
 
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
 
|style="text-align:center;" |[[Bestand:MultidisciplinaryTeamMeeting-v2.0Model(2024EN).png | 150px |link=]]<br>[[Media:MultidisciplinaryTeamMeeting-v2.0Model(2024EN).png | full-size]]
 
|style="text-align:center;" |[[Bestand:MultidisciplinaryTeamMeeting-v2.0Model(2024EN).png | 150px |link=]]<br>[[Media:MultidisciplinaryTeamMeeting-v2.0Model(2024EN).png | full-size]]
|
+
|style="text-align:center;" |[[Bestand:MultidisciplinaryTeamMeeting-v2.0Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:MultidisciplinaryTeamMeeting-v2.0Model(2024EN)_Nieuw.png | full-size]]
|-style="vertical-align: top;"
 
|[[Signaling-v2.0(2024EN)| Signaling]]
 
|[[Problem-v4.7(2024EN)|Problem]]
 
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]
 
|style="text-align:center;" |[[Bestand:Signaling-v2.0Model(2024EN).png | 150px |link=]]<br>[[Media:Signaling-v2.0Model(2024EN).png | full-size]]
 
|
 
 
|-style="vertical-align: top;"
 
|-style="vertical-align: top;"
 
|[[NursingIntervention-v4.1(2024EN)| NursingIntervention]]
 
|[[NursingIntervention-v4.1(2024EN)| NursingIntervention]]
Regel 85: Regel 92:
 
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
 
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
 
|style="text-align:center;" |[[Bestand:NursingIntervention-v4.1Model(2024EN).png | 150px |link=]]<br>[[Media:NursingIntervention-v4.1Model(2024EN).png | full-size]]
 
|style="text-align:center;" |[[Bestand:NursingIntervention-v4.1Model(2024EN).png | 150px |link=]]<br>[[Media:NursingIntervention-v4.1Model(2024EN).png | full-size]]
|
+
|style="text-align:center;" |[[Bestand:NursingIntervention-v4.1Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:NursingIntervention-v4.1Model(2024EN)_Nieuw.png | full-size]]
 
|-style="vertical-align: top;"
 
|-style="vertical-align: top;"
 
|[[NutritionAdvice-v3.2.1(2024EN)| NutritionAdvice]]
 
|[[NutritionAdvice-v3.2.1(2024EN)| NutritionAdvice]]
Regel 91: Regel 98:
 
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
 
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
 
|style="text-align:center;" |[[Bestand:NutritionAdvice-v3.2.1Model(2024EN).png | 150px |link=]]<br>[[Media:NutritionAdvice-v3.2.1Model(2024EN).png | full-size]]
 
|style="text-align:center;" |[[Bestand:NutritionAdvice-v3.2.1Model(2024EN).png | 150px |link=]]<br>[[Media:NutritionAdvice-v3.2.1Model(2024EN).png | full-size]]
|
+
|style="text-align:center;" |[[Bestand:NutritionAdvice-v3.2.1Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:NutritionAdvice-v3.2.1Model(2024EN)_Nieuw.png | full-size]]
 
|-style="vertical-align: top;"
 
|-style="vertical-align: top;"
 
|[[Procedure-v5.4.1(2024EN)| Procedure]]
 
|[[Procedure-v5.4.1(2024EN)| Procedure]]
 
|[[Problem-v4.7(2024EN)|Problem]]
 
|[[Problem-v4.7(2024EN)|Problem]]
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
+
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
 
|style="text-align:center;" |[[Bestand:Procedure-v5.4.1Model(2024EN).png | 150px |link=]]<br>[[Media:Procedure-v5.4.1Model(2024EN).png | full-size]]
 
|style="text-align:center;" |[[Bestand:Procedure-v5.4.1Model(2024EN).png | 150px |link=]]<br>[[Media:Procedure-v5.4.1Model(2024EN).png | full-size]]
|
+
|style="text-align:center;" |[[Bestand:Procedure-v5.4.1Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:Procedure-v5.4.1Model(2024EN)_Nieuw.png | full-size]]
 
|-style="vertical-align: top;"
 
|-style="vertical-align: top;"
|[[AdvanceDirective-v4.3(2024EN)| AdvanceDirective]]
+
|[[Signaling-v2.0(2024EN)| Signaling]]
 
|[[Problem-v4.7(2024EN)|Problem]]
 
|[[Problem-v4.7(2024EN)|Problem]]
 
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]
 
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]
|style="text-align:center;" |[[Bestand:AdvanceDirective-v4.3Model(2024EN).png | 150px |link=]]<br>[[Media:AdvanceDirective-v4.3Model(2024EN).png | full-size]]
+
|style="text-align:center;" |[[Bestand:Signaling-v2.0Model(2024EN).png | 150px |link=]]<br>[[Media:Signaling-v2.0Model(2024EN).png | full-size]]
|
+
|style="text-align:center;" |[[Bestand:Signaling-v2.0Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:Signaling-v2.0Model(2024EN)_Nieuw.png | full-size]]
 
|-style="vertical-align: top;"
 
|-style="vertical-align: top;"
|[[CareAgreement-v1.1(2024EN)| CareAgreement]]
+
|[[SkinDisorder-v3.4(2024EN)| SkinDisorder]]
 
|[[Problem-v4.7(2024EN)|Problem]]
 
|[[Problem-v4.7(2024EN)|Problem]]
 
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]
 
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]
|style="text-align:center;" |[[Bestand:CareAgreement-v1.1Model(2024EN).png | 150px |link=]]<br>[[Media:CareAgreement-v1.1Model(2024EN).png | full-size]]
+
|style="text-align:center;" |[[Bestand:SkinDisorder-v3.4Model(2024EN).png | 150px |link=]]<br>[[Media:SkinDisorder-v3.4Model(2024EN).png | full-size]]
|
+
|style="text-align:center;" |[[Bestand:SkinDisorder-v3.4Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:SkinDisorder-v3.4Model(2024EN)_Nieuw.png | full-size]]
 
|-style="vertical-align: top;"
 
|-style="vertical-align: top;"
|[[EpisodeOfCare-v1.0(2024EN)| EpisodeOfCare]]
+
|[[TreatmentObjective-v3.2.1(2024EN)| TreatmentObjective]]
 
|[[Problem-v4.7(2024EN)|Problem]]
 
|[[Problem-v4.7(2024EN)|Problem]]
|[[Condition-v1.0(2024EN) | Condition]]
+
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
|style="text-align:center;" |[[Bestand:EpisodeOfCare-v1.0Model(2024EN).png | 150px |link=]]<br>[[Media:EpisodeOfCare-v1.0Model(2024EN).png | full-size]]
+
|style="text-align:center;" | [[Bestand:TreatmentObjective-v3.2.1Model(2024EN).png | 150px |link=]]<br>[[Media:TreatmentObjective-v3.2.1Model(2024EN).png | full-size]]
|
+
|style="text-align:center;" | [[Bestand:TreatmentObjective-v3.2.1Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:TreatmentObjective-v3.2.1Model(2024EN)_Nieuw.png | full-size]]
|-style="vertical-align: top;"
 
|[[CareTeam-v1.0.1(2024EN)| CareTeam]]
 
|[[Problem-v4.7(2024EN)|Problem]]
 
|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
 
|style="text-align:center;" |[[Bestand:CareTeam-v1.0.1Model(2024EN).png | 150px |link=]]<br>[[Media:CareTeam-v1.0.1Model(2024EN).png | full-size]]
 
|
 
 
|}
 
|}
 +
 +
===Notes===
 +
<sup>1</sup> &nbsp;HypersensitivityIntolerance reference should only be used when it is not medication related, as that is what the HCIM SurveillanceDecision is intended for.<br>
 +
<sup>2</sup> &nbsp;An EpisodeOfCare relates to a condition that a health professional is following.

Huidige versie van 9 jul 2024 om 11:24

Reason

Upon acceptance of the revision of the HCIM Problem, in release 2024 the HCIM Problem will disappear. This means that HCIMs currently referring to the HCIM Problem will have to be modified.
The HCIM Problem represented multiple concepts and these have been modelled in separate HCIMs after the revision of the HCIM Problem.

Realisation

The following HCIMs are eligable to replace the reference to the HCIM Problem:

Depending on the nature of the concept of a HCIM currently referring to Problem, replacing the reference to the HCIM Problem requires a reference to one or more of the above HCIMs.
The table below shows, for each HCIM with a current reference to the HCIM Problem, which reference(s) will replace it.

HCIM Current reference Replacement reference(s) Current information model New information model
Admission Problem DiagnosticInsight
Reaction
Symptom
Admission-v2.0Model(2024EN).png
full-size
Admission-v2.0Model(2024EN) Nieuw.png
full-size
AdvanceDirective Problem DiagnosticInsight AdvanceDirective-v4.3Model(2024EN).png
full-size
AdvanceDirective-v4.3Model(2024EN) Nieuw.png
full-size
Alert Problem DiagnosticInsight
HypersensitivityIntolerance 1
Alert-v4.2Model(2024EN).png
full-size
Alert-v4.2Model(2024EN) Nieuw.png
full-size
CareAgreement Problem DiagnosticInsight CareAgreement-v1.1Model(2024EN).png
full-size
CareAgreement-v1.1Model(2024EN) Nieuw.png
full-size
CareTeam Problem DiagnosticInsight
Symptom
CareTeam-v1.0.1Model(2024EN).png
full-size
CareTeam-v1.0.1Model(2024EN) Nieuw.png
full-size
Encounter Problem DiagnosticInsight
HypersensitivityIntolerance
Reaction
Symptom
Encounter-v6.0Model(2024EN).png
full-size
Encounter-v6.0Model(2024EN) Nieuw.png
full-size
EpisodeOfCare Problem Condition 2 EpisodeOfCare-v1.0Model(2024EN).png
full-size
EpisodeOfCare-v1.0Model(2024EN) Nieuw.png
full-size
FamilyHistory Problem DiagnosticInsight
HypersensitivityIntolerance
FamilyHistory-v4.0Model(2024EN).png
full-size
FamilyHistory-v4.0Model(2024EN) Nieuw.png
full-size
MedicalDevice Problem DiagnosticInsight MedicalDevice-v4.0Model(2024EN).png
full-size
MedicalDevice-v4.0Model(2024EN) Nieuw.png
full-size
MedicationAgreement Problem DiagnosticInsight
HypersensitivityIntolerance
Reaction
Symptom
MedicationAgreement-v3.0Model(2024EN).png
full-size
MedicationAgreement-v3.0Model(2024EN) Nieuw.png
full-size
MultidisciplinaryTeamMeeting Problem DiagnosticInsight
Symptom
MultidisciplinaryTeamMeeting-v2.0Model(2024EN).png
full-size
MultidisciplinaryTeamMeeting-v2.0Model(2024EN) Nieuw.png
full-size
NursingIntervention Problem DiagnosticInsight
Symptom
NursingIntervention-v4.1Model(2024EN).png
full-size
NursingIntervention-v4.1Model(2024EN) Nieuw.png
full-size
NutritionAdvice Problem DiagnosticInsight
HypersensitivityIntolerance
Reaction
Symptom
NutritionAdvice-v3.2.1Model(2024EN).png
full-size
NutritionAdvice-v3.2.1Model(2024EN) Nieuw.png
full-size
Procedure Problem DiagnosticInsight
Reaction
Symptom
Procedure-v5.4.1Model(2024EN).png
full-size
Procedure-v5.4.1Model(2024EN) Nieuw.png
full-size
Signaling Problem DiagnosticInsight Signaling-v2.0Model(2024EN).png
full-size
Signaling-v2.0Model(2024EN) Nieuw.png
full-size
SkinDisorder Problem DiagnosticInsight SkinDisorder-v3.4Model(2024EN).png
full-size
SkinDisorder-v3.4Model(2024EN) Nieuw.png
full-size
TreatmentObjective Problem DiagnosticInsight
HypersensitivityIntolerance
Symptom
TreatmentObjective-v3.2.1Model(2024EN).png
full-size
TreatmentObjective-v3.2.1Model(2024EN) Nieuw.png
full-size

Notes

1  HypersensitivityIntolerance reference should only be used when it is not medication related, as that is what the HCIM SurveillanceDecision is intended for.
2  An EpisodeOfCare relates to a condition that a health professional is following.